Beta.sub.2 integrin cell adhesion molecule inhibitors
US5912266A · kind A · utility
9Cited by
2References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 13, 1997 |
| Grant date | Jun 15, 1999 |
| Priority date | — |
| Expiry date | Aug 13, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/375
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention concerns compositions and methods utilizing a compound of the formula: ##STR1## for reducing or controlling inflammation and treating pathological conditions mediated by intercellular adhesion. More particularly, the present invention concerns compositions and methods for blocking or modulating the function of the Beta.sub.2 Integrin family of cell adhesion molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.